Open-Lung Extubation for Collapsed Lung Prevention
(OLEXT-3 Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Research on lung protective strategies, like the open lung approach, shows they can reduce lung injury and improve outcomes in conditions like adult respiratory distress syndrome (ARDS). These strategies help keep the lungs open and prevent damage during mechanical ventilation, which may support their use in preventing collapsed lungs.
12345Research on lung-protective ventilation, which includes strategies similar to open-lung extubation, suggests it is generally safe and may reduce complications like lung inflammation and sepsis in surgical patients.
16789The Protective 'open-lung' extubation treatment is unique because it focuses on keeping the lung open during and after extubation by using techniques like high-pressure recruitment maneuvers and maintaining positive end-expiratory pressure, which are not typically part of standard extubation procedures.
15101112Eligibility Criteria
This trial is for patients who have undergone abdominal surgery and are at risk of lung complications like collapsed lungs or injury from a ventilator. Participants must not have any conditions that would exclude them from the study, as detailed in the provided eligibility criteria.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo elective intra-abdominal surgery with either 'open lung' or 'conventional' extubation strategy
Follow-up
Participants are monitored for postoperative pulmonary complications and other outcomes
Extended Follow-up
Participants' health-related quality of life and discharge disposition are assessed